Cargando…

Controlled Human Infection to Speed Up SARS-CoV-2 Vaccine Development

Detalles Bibliográficos
Autores principales:	Baay, Marc, Neels, Pieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994256/ https://www.ncbi.nlm.nih.gov/pubmed/33777056 http://dx.doi.org/10.3389/fimmu.2021.658783

Ejemplares similares

SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues
por: Baay, Marc, et al.
Publicado: (2020)

SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
por: Baay, Marc, et al.
Publicado: (2020)

Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic
por: Baay, Marc, et al.
Publicado: (2021)

Animal experiments show impact of vaccination on reduction of SARS-CoV-2 virus circulation: A model for vaccine development?
por: Vandeputte, J., et al.
Publicado: (2021)

SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
por: Canedo-Marroquín, Gisela, et al.
Publicado: (2020)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development
por: Alturki, Sana O., et al.
Publicado: (2020)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections
por: Qassim, Suelen H., et al.
Publicado: (2022)

Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
por: Jonny, Jonny, et al.
Publicado: (2022)

Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination
por: Graninger, Marianne, et al.
Publicado: (2022)

Editorial: Mucosal immunity to HIV and SARS-CoV-2 infection and vaccination
por: Bomsel, Morgane, et al.
Publicado: (2023)

Cannabidiol and SARS-CoV-2 Infection
por: Vallée, Alexandre
Publicado: (2022)

Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
por: Kim, Byoung-Jun, et al.
Publicado: (2021)

Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
por: Chavda, Vivek P., et al.
Publicado: (2022)

IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant
por: Bekele, Yonas, et al.
Publicado: (2021)

Editorial: Innate immune responses to SARS-CoV-2 in infected and vaccinated individuals
por: Saksena, Nitin K., et al.
Publicado: (2023)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
por: Liang, Yanwen, et al.
Publicado: (2020)

The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections
por: Föhse, Konstantin, et al.
Publicado: (2023)

Humoral Responses and Serological Assays in SARS-CoV-2 Infections
por: Galipeau, Yannick, et al.
Publicado: (2020)

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2022)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

Adherence to Sars-CoV2 vaccination in hematological patients
por: Narinx, Justine, et al.
Publicado: (2022)

Targeted vaccination and the speed of SARS-CoV-2 adaptation
por: Gandon, Sylvain, et al.
Publicado: (2022)

Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
por: Ahluwalia, Pankaj, et al.
Publicado: (2021)

Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination
por: Qi, Furong, et al.
Publicado: (2022)

The impact of SARS-CoV-2 infection and vaccination on inflammatory arthritis: a cohort study
por: Striani, Giovanni, et al.
Publicado: (2023)

Corrigendum: The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections
por: Föhse, Konstantin, et al.
Publicado: (2023)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

Development of an In Vivo Probe to Track SARS-CoV-2 Infection in Rhesus Macaques
por: Madden, Patrick J., et al.
Publicado: (2021)

Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses
por: Cao, Yingying, et al.
Publicado: (2021)

Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
por: Grobben, Marloes, et al.
Publicado: (2021)

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
por: Woopen, Christina, et al.
Publicado: (2021)

Role of COVID-19 Vaccines in SARS-CoV-2 Variants
por: Zhou, Zhou, et al.
Publicado: (2022)

SARS-CoV-2 epitopes inform future vaccination strategies
por: Shafqat, Areez, et al.
Publicado: (2022)

Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an In Silico Proteomics Approach
por: Kesarwani, Veerbhan, et al.
Publicado: (2021)

Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
por: Ahmad, Liyana
Publicado: (2021)

Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination
por: Lo Tartaro, Domenico, et al.
Publicado: (2023)

Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis
por: Nemeth, Dora, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t587prhnkg9044150brkq6s1uf